FMR’s Small Sale of Structure Therapeutics Shares Highlights Strategic Biopharma Liquidity Play
FMR LLC’s modest sale of Structure Therapeutics shares shows institutional liquidity management in biopharma, with insider buying boosting confidence in the company’s pipeline and potential market stability.
4 minutes to read